Price T Rowe Associates Inc Senti Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.41 - $0.99 $100,946 - $243,747	-246,210 Reduced 7.26%	3,147,123 $1.34 Million
Q2 2023 Aug 14, 2023	SELL	$0.6 - $1.14 $44,719 - $84,967	-74,533 Reduced 2.15%	3,393,333 $2.12 Million
Q1 2023 May 15, 2023	SELL	$1.15 - $2.06 $99,073 - $177,471	-86,151 Reduced 2.42%	3,467,866 $4.09 Million
Q4 2022 Feb 14, 2023	SELL	$1.25 - $65.2 $576,832 - $30.1 Million	-461,466 Reduced 11.49%	3,554,017 $5.01 Million
Q3 2022 Nov 14, 2022	BUY	$1.33 - $21.7 $566,444 - $9.24 Million	425,898 Added 11.86%	4,015,483 $8.71 Million
Q2 2022 Aug 15, 2022	BUY	$1.97 - $10.0 $7.07 Million - $35.9 Million	3,589,585 New	3,589,585 $7 Million

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.